← All Sponsors
SPONSOR

GeneCradle Inc

Total Trials
1
Recruiting
1
Phases
Phase 1, Phase 2
Conditions studied: Spinal Muscular Atrophy Type 3
NCT06421831 Phase 1, Phase 2
Recruiting

Evaluation of Safety and Efficacy of Gene Therapy Drug in the Treatment of Spinal Muscular Atrophy (SMA) Type 3 Patients

Spinal Muscular Atrophy Type 3
China View Trial →